Men are referred for breast imaging when they have a palpable mass or breast enlargement that may or may not be associated with pain and tenderness. Differentiation between a malignant and a benign finding is vital because it may avoid an unnecessary biopsy and lessen patient anxiety. The majority of breast findings in males are benign, with gynecomastia being the most common finding. Male breast cancer represents less than 0.5% of all breast cancers.1
Dr. Kuzmiak is Associate Professor of Radiology, and Director, Breast Imaging Division, University of North Carolina School of Medicine, CB #7510, Department of Radiology, Physicians' Office Building, Room 118, 170 Manning Drive, Chapel Hill, NC 27599; E-mail: firstname.lastname@example.org.
After participating in this activity, the diagnostic radiologist should be better able to evaluate the clinical presentation, imaging features, and management of malignant and benign lesions of the breast in the male patient.
The author and all staff in a position to control the content of this CME activity and their spouses/life partners (if any) have disclosed that they have no relationships with, or financial interests in, any commercial organizations pertaining to this educational activity.
Lippincott Continuing Medical Education Institute, Inc., is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Lippincott Continuing Medical Education Institute, Inc., designates this enduring material for a maximum of 2 AMA PRA. Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. To earn CME credit, you must read the CME article and complete the quiz and evaluation on the enclosed answer form, answering at least seven of the 10 quiz questions correctly. This continuing medical education activity expires on April 4, 2014.